Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine.
 BACK TO LIST

Laboratory Report

Patient
Name: Steenbakkers, Wilhelmina
DOB: 01-MAY-1940 (Age: 85)
Gender: female
Address:
Booischotseweg 370
4540 Jehay (Belgium)
ID: 1754-315887-1
Report
Date: 27-AUG-2024
Laboratory
dr Ample, Ex
Boulevard du Jardin Botanique 32
1000 Brussels
Requested by
Clinique des Houx
4480 Engis (Belgium)
Specimen
Collected: 26-AUG-2024

This seems not to be an HL7 Europe Laboratory Report (type coding LOINC 11502-2)

Chemistry

Test 26 Aug 2024 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 175.7 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 124.4 10 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 89.7 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 61.1 50 - 100 mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The current lipid profile is within normal limits, with improved cholesterol compared to 2021. Hematology results from 2020 show a mildly elevated hemoglobin, but other parameters are unremarkable. No significant abnormalities are present. Overall, laboratory findings are stable and do not indicate acute pathology. Continued routine monitoring is recommended.